<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: APAF-1 is a central component of the intrinsic pathway of <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, where APAF-1 dysregulation results in the development of diverse human <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to characterize the <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression levels of APAF-1 transcripts in low-risk and high-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and to elucidate whether the expression levels of APAF-1 transcripts are modulated with <z:mp ids='MP_0006042'>increased apoptosis</z:mp> in CD34(+) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> cells undergoing erythroid differentiation </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: APAF-1 (NM_181861) expression was verified, by quantitative RT-PCR, in bone marrow aspirates from 33 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), at the time of diagnosis, and in erythroid differentiation cultures from CD34(+) from <z:mpath ids='MPATH_458'>normal</z:mpath> donors and patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: APAF-1 expression was significantly higher in low-risk, compared to high-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, according to IPSS (P &lt; 0.0001), FAB (P = 0.0265), and cytogenetic risk (P = 0.0134) </plain></SENT>
<SENT sid="4" pm="."><plain>Low-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-derived differentiated erythroid cells demonstrated an increased expression of APAF-1, compared with <z:mpath ids='MPATH_458'>normal</z:mpath> cells, accompanied by an augmented rate of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: Increased expression of APAF-1 in low-risk disease and its positive correlation with the apoptotic rate observed during the erythroblast differentiation of low-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> cells may indicate that the modulation of APAF-1, at the transcriptional level, participates in the pathophysiology of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>